SBTX — Skinbiotherapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- £18.54m
- £15.79m
- £0.13m
2019 June 30th | 2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | Interim Report | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.36 | -1.62 | -1.5 | -2.99 | -3.01 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.077 | 0.156 | 0.061 | 0.053 | 0.001 |
Other Non-Cash Items | |||||
Changes in Working Capital | -0.149 | 0.567 | -0.123 | 0.227 | 0.309 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.43 | -0.892 | -1.56 | -2.67 | -2.65 |
Capital Expenditures | -0.069 | -0.074 | -0.112 | -0.097 | -0.165 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | -0 | — | — | — |
Purchase of Investments | |||||
Cash from Investing Activities | -0.069 | -0.074 | -0.112 | -0.097 | -0.165 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.44 | 0 | 4.12 | -0.035 | 2.32 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.058 | -0.966 | 2.45 | -2.8 | -0.493 |